OpenAlex
PricingAboutJobs
Log inGet started
Work

Biologic and immunomodulatory events after CTLA‐4 blockade with ticilimumab in patients with advanced malignant melanoma

HTML

Year: 2006
Type: article
Source: Cancer
DOI: 10.1002/cncr.21854
Authors: James M. Reuben, Bang‐Ning Lee, Changping Li, Jesus Gomez‐Navarro, Viviana A. Bozon, Charla A. Parker, Ingrid M. Hernandez, Carolina Gutierrez, Gabriel Lopez‐Berestein, Luis H. Camacho
Institutions: The University of Texas MD Anderson Cancer Center, Pfizer (United States)
Language: English

Topic: Cancer Immunotherapy and Biomarkers
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: CTLA-4 blockade, metastatic melanoma, regulatory T cells, immune-related adverse events, IL-10, interleukin-2, GITR, PD-1, antitumor immunity, peripheral blood mononuclear cells, immunomodulation
SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute
Award: The University of Texas M. D. Anderson Cancer Center SPORE in Melanoma
OpenAlex ID: W1973335417
FWCI: 11.37
Cites: 41
Cited by: 148
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security